Cargando…

Heart rate variability in normal-weight patients with polycystic ovary syndrome

Detalles Bibliográficos
Autor principal:	Perini, Renza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2017
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469090/ https://www.ncbi.nlm.nih.gov/pubmed/28529287 http://dx.doi.org/10.14744/AnatolJCardiol.2017.24541

Ejemplares similares

Heart rate variability in normal-weight patients with polycystic ovary syndrome
por: Kilit, Celal, et al.
Publicado: (2017)

Is polycystic ovary syndrome undervalued in China?
por: Zheng, Xu, et al.
Publicado: (2022)

Is polycystic ovary syndrome a hypothalamic disease?
por: Gaspar, Joana M.
Publicado: (2023)

Heart rate variability and heart rate turbulence in patients with polycystic ovary syndrome
por: Özkeçeci, Gülay, et al.
Publicado: (2016)

Polycystic Ovary Syndrome: Familiar to Millions?
por: Ott, Johannes
Publicado: (2020)

Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome
por: Panico, Annalisa, et al.
Publicado: (2017)

Serum C-Reactive Protein Levels in Normal-Weight Polycystic Ovary Syndrome
por: Oh, Ji Young, et al.
Publicado: (2009)

Characteristics of heart rate variability in women with polycystic ovary syndrome: A retrospective cross-sectional study
por: Ji, Hae Ri, et al.
Publicado: (2018)

Polycystic Ovary Syndrome: Past, Present and Future
por: Meczekalski, Blazej
Publicado: (2023)

Molecular Research on Polycystic Ovary Syndrome (PCOS)
por: Daniele, Simona, et al.
Publicado: (2023)

Polycystic ovary syndrome: What more can be done for patients?
por: The Lancet Regional Health – Europe
Publicado: (2022)

Visfatin and Resistin Serum Levels in Normal-Weight and Obese Women With Polycystic Ovary Syndrome
por: Farshchian, Fatemeh, et al.
Publicado: (2014)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome
por: Glintborg, Dorte, et al.
Publicado: (2022)

Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome
por: Ibáñez, Lourdes, et al.
Publicado: (2020)

Interplay of Cortisol, Testosterone, and Abdominal Fat Mass in Normal-weight Women With Polycystic Ovary Syndrome
por: Dumesic, Daniel A, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: An Apparently Simple yet Challenging Diagnosis
por: Ramezani Tehrani, Fahimeh
Publicado: (2015)

Current Management of Polycystic Ovary Syndrome: From Bench to Bedside
por: Laganà, Antonio Simone, et al.
Publicado: (2018)

Inflammatory mediators in polycystic ovary syndrome: the case of interleukin-18
Publicado: (2022)

Polycystic ovary syndrome: deciphering mechanisms to facilitate management and treatment
por: eBioMedicine
Publicado: (2023)

Heart rate in heart failure with mid-range ejection fraction
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

Abnormal heart rate recovery in patients with heart failure: an important target for exercise training treatment
por: Dimopoulos, Stavros
Publicado: (2015)

Correction to “Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome”
Publicado: (2023)

Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women
por: Dumesic, Daniel A, et al.
Publicado: (2021)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Polycystic Ovary Syndrome and Cardiovascular Diseases: Still an Open Door
por: Malachias, Marcus Vinicius Bolivar
Publicado: (2019)

Lipidomics analysis of human follicular fluid form normal-weight patients with polycystic ovary syndrome: a pilot study
por: Ban, Yanna, et al.
Publicado: (2021)

Insulin resistance and adverse metabolic profile in overweight/obese and normal weight of young women with polycystic ovary syndrome
por: Gholinezhad, Maryam, et al.
Publicado: (2018)

The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal‐weight population
por: He, Fangfang, et al.
Publicado: (2021)

Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease
por: Laganà, Antonio Simone, et al.
Publicado: (2017)

CFTR Therapeutics Normalize Cerebral Perfusion Deficits in Mouse Models of Heart Failure and Subarachnoid Hemorrhage
por: Lidington, Darcy, et al.
Publicado: (2019)

Association of Glomerular Filtration Rate with Inflammation in Polycystic Ovary Syndrome
por: Gozukara, Ilay Ozturk, et al.
Publicado: (2015)

TMT Based Proteomic Analysis of Human Follicular Fluid From Overweight/Obese and Normal-Weight Patients With Polycystic Ovary Syndrome
por: Zhang, Xinyi, et al.
Publicado: (2019)

Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
por: Pugliese, G., et al.
Publicado: (2023)

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
por: Boqun, Xu, et al.
Publicado: (2013)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5ceai9lud92t49ruujjdu6ku3m